Healthcare provider profile · identity verified

Thomas Howard Soper, D.O.

Internal Medicine · STERLING, CO · NPI 1689643900

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	275	65
Levothyroxine Sodium	Levothyroxine Sodium	267	71
Omeprazole	Omeprazole	218	55
Losartan Potassium	Losartan Potassium	202	48
Simvastatin	Simvastatin	192	50
Lisinopril	Lisinopril	179	47
Tamsulosin Hcl	Tamsulosin Hcl	167	40
Amlodipine Besylate	Amlodipine Besylate	159	40
Atorvastatin Calcium	Atorvastatin Calcium	144	38
Metformin Hcl	Metformin Hcl	106	28
Metoprolol Tartrate	Metoprolol Tartrate	94	32
Furosemide	Furosemide	93	28
Tramadol Hcl	Tramadol Hcl	93	19
Potassium Chloride	Potassium Chloride	88	17
Metoprolol Succinate	Metoprolol Succinate	86	22
Famotidine	Famotidine	82	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	82	suppressed
Meloxicam	Meloxicam	75	22
Hydrochlorothiazide	Hydrochlorothiazide	67	19
Carvedilol	Carvedilol	65	17
Pantoprazole Sodium	Pantoprazole Sodium	65	19
Warfarin Sodium	Warfarin Sodium	61	15
Duloxetine Hcl	Duloxetine Hcl	60	16
Trazodone Hcl	Trazodone Hcl	60	18
Sertraline Hcl	Sertraline Hcl	59	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	13
Pregabalin	Pregabalin	56	14
Easy Touch Pen Needle	Pen Needle, Diabetic	54	suppressed
Xarelto	Rivaroxaban	54	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	53	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	13
Clopidogrel	Clopidogrel Bisulfate	52	suppressed
Fluticasone Propionate	Fluticasone Propionate	52	15
Prednisone	Prednisone	52	28
Allopurinol	Allopurinol	51	14
Eliquis	Apixaban	50	suppressed
Finasteride	Finasteride	46	11
Tizanidine Hcl	Tizanidine Hcl	46	17
Spironolactone	Spironolactone	45	11
Sucralfate	Sucralfate	42	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	14
Donepezil Hcl	Donepezil Hcl	40	suppressed
Paroxetine Hcl	Paroxetine Hcl	40	suppressed
Ventolin Hfa	Albuterol Sulfate	38	suppressed
Mirtazapine	Mirtazapine	37	12
Terazosin Hcl	Terazosin Hcl	37	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	36	13
Methylprednisolone	Methylprednisolone	33	31
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	suppressed
Nystatin	Nystatin	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Glimepiride	Glimepiride	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	27	suppressed
Testosterone Cypionate	Testosterone Cypionate	27	suppressed
Alprazolam	Alprazolam	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Novolog Flexpen	Insulin Aspart	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Spiriva Handihaler	Tiotropium Bromide	23	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Restasis	Cyclosporine	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Baclofen	Baclofen	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Glipizide Er	Glipizide	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Ozempic	Semaglutide	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	13
Azithromycin	Azithromycin	17	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	12
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Atenolol	Atenolol	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Estradiol	Estradiol	14	suppressed
Haloperidol	Haloperidol	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Topiramate	Topiramate	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Zonisamide	Zonisamide	13	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Zileuton Er	Zileuton	12	suppressed
Budesonide Dr	Budesonide	11	suppressed
Latanoprost	Latanoprost	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error